Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2015

Mar 18, 2015

30071_dirs_2015-03-18_2947e287-c7de-4717-ab8a-20373ea82b62.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-03-16

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-03-16 ResMed Common Stock M 300 $21.675 Acquired 122655.941 Direct
2015-03-16 ResMed Common Stock S 300 $69.10 Disposed 122355.941 Direct
2015-03-16 ResMed Common Stock M 5675 $15.52 Acquired 128030.941 Direct
2015-03-16 ResMed Common Stock S 5675 $69.10 Disposed 122355.941 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-03-16 ResMed Common Stock Options $21.675 M 300 Disposed 2015-10-01 ResMed Common Stock (300) Direct
2015-03-16 ResMed Common Stock Options $15.52 M 5675 Disposed 2015-11-20 ResMed Commmon Stock (5675) Direct

Footnotes

F1: Represents date options first became exercisable. Options vest 1/4 annually.